Pub Date : 2024-04-02DOI: 10.2174/0126667975302062240328050110
Andika Chandra Putra, Jamal Zaini, R. A. Ningrum, A. Ridwanuloh, Herjuno Ari Nugroho, Ryan Haryo Setyawan, Idris, Ruby Setiawan, P. S. Sushadi, Ari Sulistyo Wulandari, A. Zannati, Indriawati, Eva Erdayani, Wahyuni, D. F. Agustiyanti, P. H. Wisnuwardhani, Zahrah Saniyyah, Budi Haryanto, A. R. H. Utomo, Novia Ayu Rahma Setyaputri
COVID-19 is a disease of SARS-CoV2 beta coronavirus infection. One way to control the progression of COVID-19 symptoms is a rapid and accurate diagnosis. The current gold standard of COVID-19 diagnostic method uses RT-PCR from nasopharyngeal (NP) swabs and sputum specimens. To assess the efficacy of saliva and rectal swabs as non-invasive alternatives to the conventional nasopharyngeal swab for RTPCR testing in COVID-19 diagnosis, with a focus on the potential benefits for healthcare providers and patient comfort. This observational study was conducted with 80 confirmed cases at a tertiary hospital in Indonesia, the study compared RTPCR positivity rates among different collection methods. A high positivity rate of 92% for nasopharyngeal swabs, with saliva and rectal swabs yielding 36% and 34%, respectively. Notably, the positivity rates for saliva and rectal samples increased to 60% and 50% when testing occurred between five to seven days post-symptom onset. Crucially, in older patients, both saliva and rectal swabs demonstrated higher positivity rates than in younger patients within the initial four days of symptom onset, with rates of 43% and 17%, respectively. Furthermore, a significant correlation was found between rectal swab positivity on day one and mortality in the older cohort, where lower Ct values on day seven were significantly associated with the deceased group. These findings support the potential of saliva and rectal swabs in predicting disease severity and patient outcomes, suggesting a safer and more convenient testing strategy for COVID- 19.
{"title":"Non-Invasive Specimen Collection in COVID-19 RT-PCR Testing: An Observational Study at an Indonesian Tertiary Hospital","authors":"Andika Chandra Putra, Jamal Zaini, R. A. Ningrum, A. Ridwanuloh, Herjuno Ari Nugroho, Ryan Haryo Setyawan, Idris, Ruby Setiawan, P. S. Sushadi, Ari Sulistyo Wulandari, A. Zannati, Indriawati, Eva Erdayani, Wahyuni, D. F. Agustiyanti, P. H. Wisnuwardhani, Zahrah Saniyyah, Budi Haryanto, A. R. H. Utomo, Novia Ayu Rahma Setyaputri","doi":"10.2174/0126667975302062240328050110","DOIUrl":"https://doi.org/10.2174/0126667975302062240328050110","url":null,"abstract":"\u0000\u0000COVID-19 is a disease of SARS-CoV2 beta coronavirus infection. One way\u0000to control the progression of COVID-19 symptoms is a rapid and accurate diagnosis. The current\u0000gold standard of COVID-19 diagnostic method uses RT-PCR from nasopharyngeal (NP) swabs and\u0000sputum specimens.\u0000\u0000\u0000\u0000To assess the efficacy of saliva and rectal swabs as non-invasive alternatives to the conventional\u0000nasopharyngeal swab for RTPCR testing in COVID-19 diagnosis, with a focus on the potential\u0000benefits for healthcare providers and patient comfort.\u0000\u0000\u0000\u0000This observational study was conducted with 80 confirmed cases at a tertiary hospital in\u0000Indonesia, the study compared RTPCR positivity rates among different collection methods.\u0000\u0000\u0000\u0000A high positivity rate of 92% for nasopharyngeal swabs, with saliva and rectal swabs yielding\u000036% and 34%, respectively. Notably, the positivity rates for saliva and rectal samples increased\u0000to 60% and 50% when testing occurred between five to seven days post-symptom onset. Crucially, in\u0000older patients, both saliva and rectal swabs demonstrated higher positivity rates than in younger patients\u0000within the initial four days of symptom onset, with rates of 43% and 17%, respectively. Furthermore,\u0000a significant correlation was found between rectal swab positivity on day one and mortality\u0000in the older cohort, where lower Ct values on day seven were significantly associated with the\u0000deceased group.\u0000\u0000\u0000\u0000These findings support the potential of saliva and rectal swabs in predicting disease\u0000severity and patient outcomes, suggesting a safer and more convenient testing strategy for COVID-\u000019.\u0000","PeriodicalId":504431,"journal":{"name":"Coronaviruses","volume":"31 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140752598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-13DOI: 10.2174/0126667975291444240209050447
Rıza Altunbaş, Aziz Batu, Adnan Türkel, Ali Akin, Umut Tendik
COVID-19 is a global pandemic that has caused significant mortality. The disease severity varies among individuals, and the factors influencing its course remain unclear. This study aimed to investigate the influence of biochemical parameters and familial data on COVID-19 outcomes. A retrospective analysis of 122 COVID-19 patients was conducted. Patients were categorized into two groups: outpatients with mild symptoms and those admitted to the intensive care unit (ICU) and intubated. Demographic data, biochemical levels of vitamin D, vitamin B12, and magnesium, and COVID-19 outcomes of first-, second-, and third-degree relatives were collected. The ICU group had a higher proportion of males (75%) and older patients (average age: 63.18±12.89 years) than the outpatient group (40% males and an average age of 45.13±13.77 years). Both groups had similar BMI, vitamin D, and vitamin B12 levels. However, magnesium levels were significantly higher in the ICU group (mean 2.25±0.3 mg/dL) than in the outpatient group (mean: 1.98±0.2 mg/dL). A significant familial relationship was identified between COVID-19 outcomes and disease course. Among the ICU patients, 25% had first-degree relatives who died from COVID- 19, compared to only 10% of the outpatient patients. Similarly, second- and third-degree relatives of ICU patients had a higher mortality rate from COVID-19 than relatives of outpatient patients. Age, gender, and magnesium levels may influence COVID-19 disease severity. Familial ties (genetic relatedness) may also play a role, suggesting potential genetic predisposition. Further research is needed to validate these findings and elucidate the underlying mechanisms
{"title":"Biochemical and Familial Factors Influencing COVID-19 Disease\u0000Progression","authors":"Rıza Altunbaş, Aziz Batu, Adnan Türkel, Ali Akin, Umut Tendik","doi":"10.2174/0126667975291444240209050447","DOIUrl":"https://doi.org/10.2174/0126667975291444240209050447","url":null,"abstract":"\u0000\u0000COVID-19 is a global pandemic that has caused significant mortality. The\u0000disease severity varies among individuals, and the factors influencing its course remain unclear. This\u0000study aimed to investigate the influence of biochemical parameters and familial data on COVID-19\u0000outcomes.\u0000\u0000\u0000\u0000A retrospective analysis of 122 COVID-19 patients was conducted. Patients were categorized\u0000into two groups: outpatients with mild symptoms and those admitted to the intensive care unit\u0000(ICU) and intubated. Demographic data, biochemical levels of vitamin D, vitamin B12, and magnesium,\u0000and COVID-19 outcomes of first-, second-, and third-degree relatives were collected.\u0000\u0000\u0000\u0000The ICU group had a higher proportion of males (75%) and older patients (average age:\u000063.18±12.89 years) than the outpatient group (40% males and an average age of 45.13±13.77 years).\u0000Both groups had similar BMI, vitamin D, and vitamin B12 levels. However, magnesium levels were\u0000significantly higher in the ICU group (mean 2.25±0.3 mg/dL) than in the outpatient group (mean:\u00001.98±0.2 mg/dL). A significant familial relationship was identified between COVID-19 outcomes\u0000and disease course. Among the ICU patients, 25% had first-degree relatives who died from COVID-\u000019, compared to only 10% of the outpatient patients. Similarly, second- and third-degree relatives of\u0000ICU patients had a higher mortality rate from COVID-19 than relatives of outpatient patients.\u0000\u0000\u0000\u0000Age, gender, and magnesium levels may influence COVID-19 disease severity. Familial\u0000ties (genetic relatedness) may also play a role, suggesting potential genetic predisposition. Further\u0000research is needed to validate these findings and elucidate the underlying mechanisms\u0000","PeriodicalId":504431,"journal":{"name":"Coronaviruses","volume":"142 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139841060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}